RxDoctor Payments Data

Kristen Braig, MD

Family Medicine · Bellefontaine, OHNPI 1265422950

Payments from drug & device makers

$443in general payments, 2019–2025

Across 27 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$161
  • Pfizer$106
  • GSK$43
  • Merck$33
  • Amgen$31
  • Boehringer Ingelheim$28
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)9$161
Pfizer7$106
GSK2$43
Merck2$33
Amgen2$31
Boehringer Ingelheim2$28
Exact Sciences1$16
Abbott1$13
AstraZeneca1$11

How this compares

$443 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$138,698
Medicare patients
350
Services billed
2,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$58,103
OzempicSemaglutide33$30,987
XareltoRivaroxaban35$30,310
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$27,743
RybelsusSemaglutide12$18,838
FarxigaDapagliflozin Propanediol21$18,643
JardianceEmpagliflozin18$18,321
OxycontinOxycodone Hcl11$16,589
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$8,826
Albuterol Sulfate HfaAlbuterol Sulfate121$2,920
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$2,807
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,916
Atorvastatin Calcium294$1,862
Gabapentin130$1,855
Levemir FlexpenInsulin Detemir13$1,754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$106$59,53364 claims
GSKTrelegy Ellipta$43$27,74339 claims
AstraZenecaFarxiga$11$18,64321 claims
Boehringer IngelheimJardiance$28$18,32118 claims
AbbVieSynthroid$161$1,12728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Bellefontaine

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →